Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer's new Vyndaqel franchise worth far more than $1.5B, analyst figures
Fierce Pharma
Thu, 05/30/19 - 12:36 pm
Tags:
Pfizer, tafamdis, ATTR, Vyndaqel
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Tue, 05/21/19 - 11:07 pm
Tags:
Verily, Alphabet, clinical trials, Pfizer, Novartis, Sanofi, Otsuka
Where Will Pfizer Be in 5 Years?
Motley Fool
Sat, 05/18/19 - 08:49 pm
Tags:
Pfizer, M&A, spin-offs, dividends
EMA imposes formal limit on Xeljanz prescription as regulators continue to review safety concerns
Endpoints
Sat, 05/18/19 - 08:47 pm
Tags:
EMA, Pfizer, Europe, Xeljanz, post-marketing studies
Pfizer’s blood clot drug Fragmin gets FDA approval for pediatric patients
Pharmaceutical Business Review
Fri, 05/17/19 - 09:57 am
Tags:
Pfizer, FDA, Fragmin, blood clots, pediatrics
Pfizer’s Abrocitinib yields positive results in phase 3 moderate to severe AD trial
Pharmaceutical Business Review
Thu, 05/16/19 - 10:55 am
Tags:
Pfizer, clinical trials, PF-04965842, atopic dermatitis
Merck and Pfizer’s Bavencio approved for renal cell carcinoma
Pharmaforum
Wed, 05/15/19 - 10:35 am
Tags:
Merck KGaA, Pfizer, Bavencio, FDA, Inlyta, advanced renal cell carcinoma
Pfizer jumps into the heated PhIII race for new-wave JAK inhibitors — but safety frets loom large
Endpoints
Wed, 05/15/19 - 10:24 am
Tags:
Pfizer, JAK inhibitors, abrocitinib, anti-inflammatories
Pfizer selects first GPCR candidate from Sosei Heptares tie-up
Pharmaforum
Tue, 05/14/19 - 09:53 am
Tags:
Pfizer, Sosei Heptares, drug development, R&D, GPCRs
[video]Top vaccine makers Merck and Pfizer target China and older adults next
Yahoo/CNBC
Sun, 05/12/19 - 01:25 pm
Tags:
vaccines, Merck, Pfizer, Sanofi Pasteur, GSK, China
How Viagra revolutionized the erectile dysfunction market
CNBC
Sat, 05/11/19 - 12:15 pm
Tags:
Pfizer, Viagra, generics, erectile dysfunction
Why dwarfism start-up Therachon picked Pfizer takeout over IPO
BioCentury
Sat, 05/11/19 - 12:12 pm
Tags:
Pfizer, Therachon, IPOs
Looking to topple Pfizer's Prevnar 13 dynasty, Merck claims another win for its 'breakthrough' pneumococcal conjugate vaccine
Endpoints
Wed, 05/8/19 - 12:30 pm
Tags:
Merck, Pfizer, vaccines, pneumococcal disease, V114, Prevnar 13, FDA
Pfizer agrees on $340M upfront to buy Therachon for dwarfism drug
Fierce Biotech
Wed, 05/8/19 - 10:42 am
Tags:
Pfizer, Therachon, short-limbed dwarfism, M&A
Can Pfizer Leap Over the Competition With This Potential Blockbuster?
Motley Fool
Wed, 05/8/19 - 10:03 am
Tags:
Pfizer, Vyndamax, tafamidis, ATTR, Alnylam, Onpattro, Akcea Therapeutics, Tegsedi, Eidos Therapeutics, AG10
Pfizer Calls for Compromise on Retroactively Using Suffixes in Biologic Names
RAPS.org
Tue, 05/7/19 - 06:47 pm
Tags:
Pfizer, FDA, suffixes, drug names, biologics, biosimilars
Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For It
Forbes
Mon, 05/6/19 - 07:27 pm
Tags:
Pfizer, tafamidis, insurers, PBMs, ATTR
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
Xconomy
Mon, 05/6/19 - 10:54 am
Tags:
FDA, Pfizer, tafamidis, Vyndaqel, Vyndamax, ATTR, Alnylam, Akcea
ED Drug Shows Promise in Sheep Heart Failure Study
BioSpace
Mon, 05/6/19 - 10:48 am
Tags:
heart failure, tadalafil, Pfizer, Viagra, Eli Lilly, Cialis
Pfizer prospects for tafamidis market
Biopharma Dive
Tue, 04/30/19 - 05:38 pm
Tags:
Pfizer, tafamidis, transthyretin amyloid cardiomyopathy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.